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53ET-13 Conference Program
Sunday, September 8, 2013
16:00–19:30
Registration
18:00–20:00
Welcome Cocktail, Tokyo Dome Hotel
Monday, September 9, 2013
8:30–8:40
Opening Remarks by the Conference Chairs
8:40–9:45
Session 1: New Aspects of Endothelin in Physiology and Disease
8:40–9:00
Invited Lecture 1
Interaction and Sexual Dimorphism of ETB/NOS Signaling in Cardiovascular
and Renal Disease
Jennifer S. Pollock
Experimental Medicine, Georgia Regents University, Augusta, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
9:00–9:20
Invited Lecture 2
Endothelin is Getting Older: How Aging Links Endothelin with Disease
Matthias Barton
University of Zurich, Switzerland
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
9:20–9:45
Oral Presentations
Development of Osteoarthritis-like Changes in Transgenic Endothelin-1
Over-expressed Mice
Chunyi Wen
University of Hong Kong, Hong Kong, China
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Characterisation Of the "Endothelin-Like Domain Peptide" (ELDP) Co-syn-
thesised With Endothelin-1 from the EDN1 gene
Jale Yuzugulen
Queen Mary University of London, London, UK
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
9:45–10:30
Session 2: Oncology
9:45–10:05
Keynote Lecture 1
The Endothelin Axis: A New Player in Tumor Angiogenesis and
Lymphangiogenesis
Francesca Spinella
Regina Elena National Cancer Institute, Rome, Italy
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)10:05–10:30
Oral Presentations
Endothelin-1 Induced Mxi-2/Ago2 Complex Formation Resulting in p53
Downregulation Promoting Breast Cancer Development
Melanie von Brandenstein
University of Cologne, Cologne, Germany
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Tamoxifen Treatment in Breast Cancer Induces a Cytoplasmic Complex
Consisting of Endothelin-1, Estrogen Receptors, and Tamoxifen Leading to
Nuclear Transmigration, and Transcription of Target Genes Involved in
Metastatic Spread
Julia Straube
University of Rhein-Bonn-Sieg, Sankt Augustin, Germany
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
10:30–10:55
Coffee Break
10:55–12:05
Session 3: Renal Diseases
10:55–11:15
Keynote Lecture 2
The Role of Endothelin in Glomerular Diseases: Cellular Culprits, Cellular
Targets
Pierre-Louis Tharaux
University Paris-Descartes, Paris, France
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:15–12:05
Oral Presentations
Heterozygous Overexpression of Preproendothelin-1 in Endothelial Cells
Enhances Thromboxane-Prostanoid Receptor-Induced Contractions in the
Renal Artery of Obese Mice
Oliver Baretella
University of Hong Kong, Hong Kong, China
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
The Effect of Proteinuria-Mediated Endothelin-1 Downregulation of PKCα
Signalling in Proximal Tubular Cells and Its Successul Treatment is Measur-
able Using MicroRNA15a as Biomarker in Vitro and in Vivo
Heike Loeser
University Hospital Cologne, Cologne, Germany
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
ET-B Receptors in Podocytes Promote Diabetic Glomerulosclerosis with
β-catenin and NFκB Activation
Olivia Lenoir
Paris Cardiovascular Research Centre (INSERM), Paris, France
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Changes in Urinary ET-1 Excretion in Response to Increased Renal Perfusion
Pressure in the Rat
Geoff J. Culshaw
The Queens Medical Research Institute, Edinburgh, UK
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
12:15–13:15
54Lunch Session 1
Recent Progress in the Management of Pulmonary Arterial Hypertension
Hiroshi Watanabe
Hamamatsu University School of Medicine, Hamamatsu, Japan
12:15–13:15
Lunch Session 2
Medical Treatment for Type II Diabetes Mellitus for Inhibiting Vascular
Events
Toyoaki Murohara
Nagoya University, Nagoya, Japan
13:15–14:45
Poster Session 1
Oncology, Renal Physiology andDisease, Neurology, Infectious Diseases,
New Topics of Endothelin Biology
14:45–15:35
Session 4: Resistant Hypertension
14:45–15:10
Invited Lecture 3
Treatment-Resistant Hypertension: The Challenges for Drug Treatment
David J. Webb
University of Edinburgh, UK
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:10–15:35
Invited Lecture 4
Impact of Neuromodulation on Pressure Dysregulation— FromHypertension
to Hypotension —
Kenji Sunagawa
Kyushu University, Fukuoka, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:35–16:05
Coffee Break
16:05–17:05
Session 5: Neurology, Pain and Stroke
16:05–16:25
Invited Lecture 5
Targeting Endothelin Axis to Treat Pain
Anil Gulati
Midwestern University, Chicago, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
16:25–17:05
Oral Presentations
Endothelin B Receptor Agonist, IRL-1620, Enhances Neurovascular Remod-
eling Following Cerebral Ischemia in Rats
Mary G. Leonard
Midwestern University, Downers Grove, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Endothelin Receptor A as a Modulator of Photoreceptor Signaling
Vicente Bermudez
Universidad Austral, Argentina
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)Endothelin-1 Treatment Induces Experimental Cerebral Malaria During
Plasmodium Berghei NK65 Infection
Yuri C. Martins
Albert Einstein College of Medicine, New York, USA
17:05–17:45
Session 6: Actual Applications and Future Perspectives of Dual ETA/
ETB Antagonists
17:05–17:25
Invited Lecture 6
Beneﬁts of Dual Endothelin Receptor Antagonists: Mechanisms of Action,
Current Studies, and Future Directions
Martine Clozel
Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
17:25–17:45
Invited Lecture 7
Effects of Bosentan on Digital Ulcers in Patients with Systemic Sclerosis
Yasushi Kawaguchi
Tokyo Women's Medical University, Tokyo, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
18:30–21:30
Social Event for Young Investigators
Tuesday, September 10, 2013
8:30–10:10
Session 7: Gene Regulation, Molecular and Cellular Biology
8:30–8:50
Invited Lecture 8
Tissue-Speciﬁc and Time-Dependent Regulation of the Endothelin Axis by
the Circadian Clock Protein Per1
Michelle L. Gumz
University of Florida, USA
8:50–9:10
Invited Lecture 9
Endothelin Signaling in Craniofacial and Cardiac Development
Hiroki Kurihara
The University of Tokyo, Tokyo, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
9:10–10:10
Oral Presentations
Erythropoietin Induced Blood Pressure Rise, Vascular Inﬂammation andOx-
idative Stress in Mice Overexpressing Human Endothelin-1: Improvement
by Exercise
Pierre Paradis
McGill University, Montreal, Canada
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Endothelin-1-Induced Oxidative Stress and Inﬂammatory Cell Inﬁltration
Contribute to High-Fat Diet Induced-Atherosclerosis and Aneurysm Forma-
tion in Apolipoprotein E Knockout Mice
Pierre Paradis
McGill University, Montreal, Canada
55(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Flow Regulation of Inner Medullary Collecting Duct Endothelin-1 Production
Meghana M. Pandit
University of Utah Health Sciences Center, Salt Lake City, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Ubiquitin Modiﬁcation Plays an Important Role in ET-1-Dependent
Endothelin Type B Receptor Trafﬁcking
Koji Terada
Hokkaido University, Sapporo, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Aldosterone Alters Chromatin Structure of the Murine Endothelin-1 Gene
Amanda K. Welch
University of Florida, Gainsville, USA
10:10–10:40
Coffee Break
10:40–12:06
Session 8: Pulmonary Hypertension
10:40–11:05
Keynote Lecture 3
The Evolving Paradigmof Pulmonary Arterial Hypertension and the Evolving
Role of Endothelin-1
David Langleben
McGill University, Montreal, Canada
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:05–11:30
Invited Lecture 10
Balloon Pulmonary Angioplasty as a Treatment Option for Chronic Throm-
boembolic Pulmonary Hypertension
Hiromi Matsubara
National Hospital OrganizationOkayamaMedical Center, Okayama, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:30–12:10
Oral Presentations
Adipose-Derived Regenerative Cells Therapy Improves Monocrotaline
Induced Rat Pulmonary Arterial Hypertension with Suppressing
Endothelin-1 though an Anti-Inﬂammatory Mechanism
Masamichi Eguchi
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki,
Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Role of Bradykinin and Endothelin-Converting Enzyme-1 in Pulmonary Hy-
pertension
Sunu B. Raharjo
University of Indonesia, Jakarta, Indonesia
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Long-Term Survival in Japanese Patients with Idiopathic/Heritable Pulmo-
nary Arterial Hypertension
Aiko OgawaNational Hospital Organization Okayama Medical Center, Okayama,
Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
12:15–13:15
Lunch Session 3
Twenty-Five Years of Research Leading to a New Generation of
Endothelin Receptor Antagonists
Martine Clozel
Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
12:15–13:15
Lunch Session 4-1
The Roles of Endothelin Receptor Antagonists and Phosphodiesterase Type 5
Inhibitors in the Management of Skin Ulcers in Systemic Sclerosis
Yoshihide Asano
University of Tokyo, Tokyo, Japan
Lunch Session 4-2
The Challenge to Refractory Pulmonary Hypertension Associated with
Scleroderma
Masaru Hatano
University of Tokyo, Tokyo, Japan
13:15–14:45
Poster Session 2
Gene Regulation, Molecular and Cellular Biology, Pharmacology,
Pulmonary Hypertension
14:45–16:05
Session 9: Blocking the ETA Receptors: What's New?
14:45–15:05
Invited Lecture 11
Endothelin Receptor Selectivity in Patients with Pulmonary Arterial
Hypertension (PAH)
Ronald Oudiz
Harbor-UCLA Medical Center, Torrance, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:05–15:25
Invited Lecture 12
Age-Dependent Antihypertensive and Antiproteinuric Effects of ETA Receptor
Blockade in Ren-2 Transgenic Rats
Ivana Vaněčková.
Institute of Physiology, Prague, Czech Republic
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:25–15:45
Invited Lecture 13
Dual Endothelin A and Angiotensin Receptor Blockers in the Treatment of
Hypertension and Renal Disease
Donald Kohan
University of Utah, Salt Lake City, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:45–16:05
Invited Lecture 14
Good and Bad News about Single and Dual Biphenyl Endothelin ETA
and Angiotensin AT1 Receptor Antagonists
56Jo G. R. De Mey
University of Southern Denmark, Odense, Denmark
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
16:05–16:30
Coffee Break
16:30–16:45
Young Investigator Award Ceremony
16:45–17:15
Honorary Chair Session
Invited Lecture 15
End o′ the Line Revisited
Paul M. Vanhoutte
University of Hong Kong, Hong
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
17:15–17:45
Special Guest Session
Invited Lecture 16
Multiple and Integrative Approaches to Cardiovascular Diseases with
Stem Cell Technology
Jun K. Yamashita
Kyoto University, Kyoto, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
19:00–21:00
Conference Dinner at Tokyo Dome Hotel
Celebration of the 25th Anniversary of the Discovery of Endothelin
Wednesday, September 11, 2013
8:30–10:00
Session 10: Cardiology, Hypertension, Vascular Disease
8:30–8:55
Keynote Lecture 4
Endothelin in Myocardial Infarction
Theoﬁlos M. Kolettis
University of Ioannina, Greece
8:55–9:55
Oral Presentations
Endothelin-1 is a Key Candidate to Exert Pathophysiological Effects on
Cardiomyocytes Derived from Hypertrophic Cardiomyopathy-Induced Plu-
ripotent Stem Cell
Atsushi Tanaka
Keio University School of Medicine, Tokyo, Japan
Endothelin Receptor Antagonists Exacerbate Autoimmune Myocarditis
in Mice
Kazuko Tajiri
University of Tsukuba, Tsukuba, Japan
Imaging of the Binding of ET-1 and of Linear ET-1 in Rat Mesenteric Resis-
tance Arteries
Dimitrios Kapsokalyvas
Maastricht University, Maastricht, The Netherlands
Sympathetic endothelin A receptors contribute to the development of
heart failureJohannes P. Backs
Heidelberg University, Heidelberg, Germany
Mouse Mast Cell Protease-4-Dependent Production of ET-1 (1-31) and of
Plaque Progression in a Apolipoprotein E Knock-Out Mouse Model of Spon-
taneous Atherosclerosis
Martin Houde
Sherbrooke University, Montreal, Canada
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
10:00–10:30
Coffee Break
10:30–12:05
Session 11: Clinical Studies Update
10:30–10:55
Keynote Lecture 5
Endothelin Receptor Antagonists in Clinical Research — Lessons Learned
Berthold Hocher
Institute of Nutritional Science, University of Potsdam, Germany
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
10:55–11:20
Invited Lecture 17
Endothelin Receptor Antagonism Versus Combined ECE/NEP Inhibition in
Patients with Type 2 Diabetes and Nephropathy
Ariela Benigni
IRCCS — Istituto Mario Negri, Bergamo, Italy
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:20–11:35
Invited Lecture 18
The Selective Type A Endothelin Antagonist Atrasentan Reduces Residual
Albuminuria in Patients with Type 2 Diabetes and Nephropathy
Dennis L. Andress
AbbVie, Chicago, IL, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:35–11:50
Invited Lecture 19
A Placebo-Controlled Study of Ambrisentan in Subjects with Idiopathic
Pulmonary Fibrosis (ARTEMIS-IPF)
Hunter Gillies
Gilead Sciences Inc. Foster City, CA, USA
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
11:50–12:05
Oral Presentations
Impact of Short Term Endothelin A Receptor Blockade on Plasma Markers
for Remodeling and Neutrophil Activation in Patients with ST Elevation
Acute Coronary Syndrome
Raphael Wurm
Medical University of Vienna, Vienna, Austria
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
12:15–13:15
Lunch Session 5
Heart Failure in PAH: Focus on the Right Ventricle
57Ronald Oudiz
Harbor-UCLA Medical Center, Torrance, USA
12:15–13:15
Lunch Session 6
How to Treat the Patients with Hypertension for the Prevention of Heart
Failure — The Back and Forth Strategy between Basic Science and Clinical
Medicine —
Masafumi Kitakaze
National Cerebral and Cardiovascular Center, Suita, Japan
13:15–14:45
Poster Session 3
Hypertension, Vascular Diseases, Cardiology, Clinical Studies, Metabolism
14:45–15:45
Session 12: Metabolism, Diabetes and Obesity
14:45–15:05
Keynote Lecture 6
Role of Endothelin in Vascular Dysfunction in Human Obesity and Diabetes
Carmine Cardillo
Catholic University Medical School, Rome, Italy
15:05–15:45
Oral Presentations
Molecular Mechanism for Suppression of Insulin Signaling by Endothelin-1
in Skeletal Muscle Cells
Takahiro Horinouchi
Hokkaido University, Sapporo, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)Plasma endothelin-1 level is associated with cardiac ﬁbrosis and diastolic
dysfunction in diabetes
Bambang Widyantoro
University of Indonesia, Jakarta, Indonesia
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
Activation of ET-1-Mediated PKC-Epsilon/ERK1/2 Pathway Contributes to
the Augmented Contractile Response in Aorta from Young Obese Rats
Fernando P. Filgueira
University of São Paulo, Ribeirão Preto, Brazil
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
15:45–16:15
Coffee Break
16:15–16:30
The Second Tomoh Masaki Award Ceremony
The ET-13 Best Presentation and Best Poster Award Ceremony
16:30–17:00
Session 13: Highlights of ET-13
Masashi Yanagisawa
University of Tsukuba, Tsukuba, Japan
(see http://endothelins.com/Educational_Media/ET-13_Lectures/ to
view this presentation)
17:00–17:15
Closing Remarks by the Conference Chairs
